Paul F. Engstrom
#159,265
Most Influential Person Now
Paul F. Engstrom's AcademicInfluence.com Rankings
Paul F. Engstromphilosophy Degrees
Philosophy
#9128
World Rank
#12638
Historical Rank
Logic
#6120
World Rank
#7603
Historical Rank
Download Badge
Philosophy
Why Is Paul F. Engstrom Influential?
(Suggest an Edit or Addition)Paul F. Engstrom's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Prognostic effect of weight loss prior tochemotherapy in cancer patients (1980) (2049)
- Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. (2017) (999)
- Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. (1980) (951)
- NCCN Clinical Practice Guidelines in Oncology: colon cancer. (2009) (947)
- Chemoprevention of cancer. (1994) (804)
- Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. (2018) (634)
- NCCN Guidelines Insights: Colon Cancer, Version 2.2018. (2018) (619)
- Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study. (1985) (485)
- Psychological and behavioral implications of abnormal mammograms. (1991) (480)
- Factors associated with repeat adherence to breast cancer screening. (1990) (470)
- Mammography adherence and psychological distress among women at risk for breast cancer. (1993) (424)
- Rectal cancer. (2007) (396)
- Screening mammography: a missed clinical opportunity? Results of the NCI Breast Cancer Screening Consortium and National Health Interview Survey Studies. (1990) (358)
- NCCN Clinical Practice Guidelines in Oncology: rectal cancer. (2009) (324)
- Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis. (1995) (307)
- Neuroendocrine tumors, version 1.2015. (2015) (291)
- NCCN Clinical Practice Guidelines in Oncology: neuroendocrine tumors. (2009) (275)
- Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer—A Plan to Move Forward (2006) (272)
- Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma. (1991) (259)
- Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor. (1984) (241)
- How valid are mammography self-reports? (1990) (240)
- Why women resist screening mammography: patient-related barriers. (1989) (240)
- Colon cancer, version 3.2014. (2014) (236)
- NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018. (2018) (234)
- Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer. (2011) (212)
- Why do some women get regular mammograms? (1991) (194)
- Telephone counseling improves adherence to colposcopy among lower-income minority women. (1992) (182)
- Relative risk of prostate cancer for men with affected relatives: Systematic review and meta‐analysis (2003) (180)
- Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A phase II study (1993) (180)
- Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk. (1997) (179)
- Rectal cancer, version 2.2015: Featured updates to the NCCN guidelines (2015) (167)
- Senior adult oncology clinical practice guidelines in oncology. (2012) (163)
- Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines. (2013) (159)
- Promoting mammography use through progressive interventions: is it effective? (1994) (156)
- Augmentation of the human immune response by cyclophosphamide. (1982) (149)
- A pilot study of preoperative chemoradiation for patients with localized adenocarcinoma of the pancreas. (1995) (144)
- Decision-making strategies for patients with localized prostate cancer. (2002) (141)
- Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk. (1996) (134)
- Rectal Cancer, Version 2.2015. (2015) (133)
- Neuroendocrine and adrenal tumors, version 2.2018 featured updates to the nccn guidelines (2018) (131)
- Neuroendocrine tumors: Clinical Practice Guidelines in Oncology™ (2012) (130)
- Postoperative adjuvant 5‐fluorouracil plus methyl‐CCNU therapy for gastric cancer patients. Eastern cooperative oncology group study (EST 3275) (1985) (126)
- Brief physician-initiated quit-smoking strategies for clinical oncology settings: a trial coordinated by the Eastern Cooperative Oncology Group. (2003) (125)
- Cancer risk notification: psychosocial and ethical implications. (1991) (122)
- Multistrategy health education program to increase mammography use among women ages 65 and older. (1992) (112)
- Effects of coping style and relaxation on cancer chemotherapy side effects and emotional responses (1990) (111)
- Oxygen tension in human tumors: in vivo mapping using CT-guided probes. (1985) (110)
- Carcinoids: The association of histologic growth pattern and survival (1983) (110)
- Enhancing cancer pain control regimens through patient education. (1987) (109)
- Cancer of unknown primary site. (2010) (107)
- Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy: a national comprehensive cancer network analysis. (2013) (104)
- Adherence to colorectal cancer screening in an HMO population. (1990) (102)
- Hospital procedure volume and teaching status do not influence treatment and outcome measures of rectal cancer surgery in a large general population (2000) (100)
- Successful application of microarray technology to microdissected formalin-fixed, paraffin-embedded tissue. (2007) (98)
- Nonsurgical management of esophageal cancer: report of a study of combined radiotherapy and chemotherapy. (1987) (97)
- Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. (2018) (93)
- Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz. (1996) (88)
- Colon cancer. Clinical practice guidelines in oncology. (2005) (86)
- Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study (2016) (86)
- The impact of mailing psychoeducational materials to women with abnormal mammograms. (1992) (85)
- Colorectal Cancer Survivorship: Movement Matters (2011) (84)
- A randomized prospective comparison of methotrexate with a combination of methotrexate, bleomycin, and cisplatin in head and neck cancer (1985) (79)
- Glutathione S-Transferase Activity and Glutathione S-Transferase μ Expression in Subjects with Risk for Colorectal Cancer (1995) (78)
- Anal Carcinoma, Version 2.2012: featured updates to the NCCN guidelines. (2012) (76)
- Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines. (2013) (73)
- Localized Colon Cancer, version 3.2013 (2013) (72)
- Markers of cell proliferation in normal epithelia and dysplastic leukoplakias of the oral cavity. (1998) (70)
- Results of combined modality therapy for patients with anal cancer (E7283). An eastern cooperative oncology group study (1995) (65)
- Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trials (2020) (61)
- Recruiting high risk women into a breast cancer health promotion trial. (1994) (59)
- Clinical, demographic and psychosocial correlates of complementary and alternative medicine use by men diagnosed with localized prostate cancer. (2003) (59)
- Informed consent: a crucial step in cancer patient education. (1984) (58)
- Decision making about prophylactic oophorectomy among at-risk women: psychological influences and implications. (1999) (58)
- A phase II trial of tamoxifen in hepatocellular carcinoma (1990) (56)
- Phase II evaluation of mitomycin and cisplatin in advanced esophageal carcinoma. (1983) (55)
- Biologic markers of risk in nipple aspirate fluid are associated with residual cancer and tumour size (1999) (54)
- Impact of an HMO-based intervention to increase mammography utilization. (1993) (54)
- Phase I/pharmacokinetic reevaluation of thioTEPA. (1991) (54)
- NCCN clinical practice guidelines in oncology. Anal carcinoma. (2010) (54)
- Preclinical and clinical evaluation of broccoli supplements as inducers of glutathione S-transferase activity. (1997) (51)
- Eligibility and extrapolation in cancer clinical trials. (1987) (51)
- Anal carcinoma: Clinical practice guidelines in oncology™ (2010) (51)
- Psychological and Screening Profiles of First-Degree Relatives of Prostate Cancer Patients (2001) (50)
- Effectiveness of botulinum toxin therapy for essential blepharospasm. (1987) (50)
- Biological markers in smoking cessation treatment. (1993) (47)
- NCCN molecular testing white paper: effectiveness, efficiency, and reimbursement. (2011) (45)
- Prostate-specific antigen production in the female breast: association with progesterone. (1998) (45)
- Colon cancer clinical practice guidelines in oncology. (2005) (45)
- A single institutional experience with preoperative chemoradiotherapy for stage I-III pancreatic adenocarcinoma. (1993) (42)
- Evaluation of nilotinib in advanced GIST previously treated with imatinib and sunitinib (2011) (41)
- Reducing avoidable cancer mortality through prevention and early detection regimens. (1989) (41)
- Coordinate induction of glutathione S-transferase alpha, mu, and pi expression in murine liver after a single administration of oltipraz. (1994) (41)
- Some reasons for compliance and noncompliance in a health maintenance organization breast cancer screening program. (1988) (40)
- Cytogenetic effects of bleomycin therapy in man. (1971) (40)
- Breast Screening Practices Among Primary Physicians: Reality And Potential (1990) (39)
- NCCN COLORECTAL CANCER PRACTICE GUIDELINES (1996) (39)
- Strategies to encourage mammography use among women in senior citizens' housing facilities. (1998) (38)
- The Effect Of A Comprehensive Breast Screening Program On Self-Reported Mammography Use By Primary Care Physicians And Women In A Health Maintenance Organization (1993) (37)
- Chemotherapy of advanced colorectal carcinoma: Fluorouracil alone vs. two drug combinations using fluorouracil, hydroxyurea, semustine, dacarbazine, razoxane, and mitomycin A phase III trial by the Eastern Cooperative Oncology Group (EST 1278) (1984) (36)
- Management of adenocarcinoma of the esophagus with chemoradiation alone or chemoradiation followed by esophagectomy : results of sequential nonrandomized phase II studies (1995) (35)
- Genetic susceptibility and dietary patterns in lung cancer. (2004) (34)
- Angiomatous lymphoid hamartoma associated with chronic anemia, hypoferremia, and hypergammaglobulinemia. (1972) (33)
- Planning a cancer control program for older citizens. (1983) (32)
- The dentist as a referral source of first episode head and neck cancer patients. (1983) (31)
- Systemic Therapy for Advanced or Metastatic Colorectal Cancer: National Comprehensive Cancer Network Guidelines for Combining Anti‐Vascular Endothelial Growth Factor and Anti‐Epidermal Growth Factor Receptor Monoclonal Antibodies with Chemotherapy (2008) (31)
- Psychosocial correlates of intention to undergo prophylactic oophorectomy among women with a family history of ovarian cancer. (2003) (30)
- Disseminated Mycobacterium kansasii infection: successful treatment of a patient with pancytopenia. (1972) (30)
- Coping with ovarian cancer risk: the moderating effects of perceived control on coping and adjustment. (2006) (29)
- Clinical trial with subcutaneously administered 5-azacytidine (NSC-102816). (1974) (28)
- Psychological Interventions and Genetic Testing: Facilitating Informed Decisions About BRCA1/2 Cancer Susceptibility (1998) (28)
- Rectal cancer clinical practice guidelines in oncology. (2005) (27)
- Prostate cancer risk assessment program. A model for the early detection of prostate cancer. (1999) (27)
- Tamoxifen therapy for metastatic carcinoid tumor: a negative study. (1984) (27)
- Clinical Practice Guidelines in Oncology TM (2009) (26)
- Academic detailing: a model for in-office CME. (1993) (26)
- A phase II trial of the proteasome inhibitor bortezomib in patients with advanced biliary tract cancers. (2014) (24)
- Glutathione S-transferase activity and glutathione S-transferase mu expression in subjects with risk for colorectal cancer. (1995) (24)
- Genetic susceptibility and dietary patterns in lung cancer (2003) (24)
- NCCN Colorectal Cancer Practice Guidelines. The National Comprehensive Cancer Network. (1996) (24)
- Can molecular imaging predict response to preoperative chemoradiation in patients with rectal cancer? A Fox Chase Cancer Center prospective experience. (2005) (22)
- CT-guided laser therapy in resistant human tumors: phase I clinical trials. (1987) (21)
- Colon Cancer , Version 3 . 2014 Clinical Practice Guidelines in Oncology (2014) (21)
- A survey of physicians' views and practices on patient education for smoking cessation. (1986) (20)
- Corporate-sponsored breast cancer screening at the work site: results of a statewide program. (1991) (20)
- Advances in cancer control (1989) (20)
- Weekly 5-fluorouracil combined with PALA: toxic and therapeutic effects in colorectal cancer. (1987) (19)
- Assessing compliance with national comprehensive cancer network guidelines for elderly patients with stage III colon cancer: the Fox Chase Cancer Center Partners' initiative. (2011) (18)
- Feasibility of a telephone survey to recruit health maintenance organization members into a tamoxifen chemoprevention trial. (1992) (18)
- Gallbladder adenocarcinoma: The prognostic significance of histologic grade (1987) (18)
- Results of an office-based training program in clinical breast examination for primary care physicians. (1996) (17)
- Management of adenocarcinoma of the esophagus with chemoradiation alone or chemoradiation followed by esophagectomy: results of sequential nonrandomized phase II studies. (1995) (17)
- Phase II study of ICRF-159 in patients with metastatic colorectal carcinoma previously exposed to systemic chemotherapy. (1976) (17)
- Pembrolizumab (P) monotherapy in patients with previously treated metastatic high grade neuroendocrine neoplasms (HG-NENs). (2018) (17)
- Smoking cessation counseling by russian oncologists: Opportunities for intervention in the russian federation (2006) (16)
- Prevalence and correlates of tobacco use among Russian cancer patients: Implications for the development of smoking cessation interventions at a cancer center in Russia (2006) (16)
- Improving cancer patients' pain control through education. (1987) (16)
- Barriers and facilitators to compliance with routine mammographic screening. (1989) (16)
- Treatment of advanced measurable or evaluable pancreatic carcinoma with 17-1A murine monoclonal antibody alone or in combination with 5-fluorouracil, adriamycin and mitomycin (FAM). (1986) (16)
- Rectal cancer. Clinical practice guidelines in oncology. (2003) (16)
- Primary Neoplasms of the Liver (2003) (15)
- Image analysis of p53 and cyclin D1 expression in premalignant lesions of the oral mucosa. (1999) (15)
- Update: NCCN colon and rectal cancer clinical practice guidelines. (2004) (15)
- Colon Cancer , Version 2 . 2018 Featured Updates to the NCCN Guidelines (2018) (14)
- Implementation of a Comprehensive Cancer Control Program at the Worksite: Year One Summary Report (2002) (14)
- Association Between Benign Breast Disease in African American and White American Women and Subsequent Triple-Negative Breast Cancer (2017) (14)
- Circulating tumor markers and assessment or response to intrahepatic chemotherapy of colon carcinoma (1985) (14)
- Prostate Cancer Risk Assessment Program (1999) (14)
- Construction and Analysis of the NCI-EDRN Breast Cancer Reference Set for Circulating Markers of Disease (2014) (13)
- An examination of compliance and noncompliance in an HMO cancer screening program. (1988) (13)
- Paclitaxel by 24- or 1-hour infusion n combination with carboplatin in advanced non-small cell lung cancer: the Fox Chase Cancer Center experience. (1995) (12)
- A pilot study of combined radiotherapy and chemotherapy for esophageal carcinoma (1984) (12)
- Educating older adults about their increased cancer risk. (1988) (12)
- Phase II trial of topotecan in advanced or metastatic adenocarcinoma of the pancreas (1995) (12)
- Chemoprevention of colorectal cancer: dietary and pharmacologic approaches. (1999) (12)
- Chronic dosing of oltipraz in people at increased risk for colorectal cancer. (2001) (11)
- Change in worksite smoking behavior following cancer risk feedback: a pilot study. (2005) (11)
- A phase II trial of the proteasome inhibitor bortezomib in patients with recurrent or metastatic adenocarcinoma of the bile duct or gallbladder (NCI #6135). (2009) (11)
- Skin necrosis associated with warfarin sodium. (1970) (10)
- Meeting the 12 lymph nodes (LN) benchmark in colorectal cancer surgery: A comparison of NCCN and SEER data (2007) (10)
- Genetic Analysis of Polymorphisms in Dopamine Receptor and Transporter Genes for Association with Smoking among Cancer Patients (2012) (10)
- G-6-PD tripler: a unique variant associated with chronic hemolytic disease. (1970) (10)
- Carcinoids: The prognostic effect of primary site histologic type variations (1986) (9)
- Anal canal cancer. Clinical practice guidelines in oncology. (2003) (9)
- Correlates of Continued Tobacco Use and Intention to Quit Smoking Among Russian Cancer Patients (2011) (9)
- Sequential methotrexate and 5‐fluorouracil with bleomycin and cisplatin in the chemotherapy of advanced squamous cancer of the head and neck (1986) (8)
- Combination chemotherapy containing semustine (MeCCNU) in patients with advanced colorectal cancer previously treated with 5‐fluorouracil (5‐Fu) (1983) (8)
- Chemotherapy of large bowel carcinoma—fluorouracil (FU) + hydroxyurea (HU) vs. methyl‐CCNU, oncovin, fluorouracil, and streptozotocin (MOF‐Strep): An Eastern Cooperative Oncology Group study (1985) (8)
- Colon cancer. (2007) (8)
- Preoperative chemotherapy and radiation therapy for patients with pancreatic carcinoma without demonstrable metastatic disease: The fox chase cancer center experience (1995) (8)
- E4206: AMG 706 and Octreotide in Patients with Low‐Grade Neuroendocrine Tumors (2018) (7)
- Cancer patients' recall of important information. (1984) (7)
- Hepatotoxicity of 5-azacytidine (NSC-102816) (a clinical and pathologic study). (1973) (6)
- Non-surgical management of esophageal cancer (1986) (6)
- Satisfaction among cancer outpatients. (1988) (6)
- Phase III study of ICRF-159 versus 5-FU in the treatment of advanced metastatic colorectal carcinoma. (1980) (6)
- Educating the older cancer patient: obstacles and opportunities. (1984) (6)
- Modification and implementation of NCCN guidelines on colon cancer in the Middle East and North Africa region. (2010) (6)
- Phase II trial of cisplatin in advanced gastric cancer. (1984) (6)
- Tobacco control in the physician's office: a matter of adequate training and resources. (2004) (6)
- Phase II trial of razoxane (ICRF-159) in patients with squamous cell carcinoma of the head and neck previously exposed to systemic chemotherapy. (1982) (6)
- Prevention of Tobacco-Related Cancer (2003) (6)
- Emerging therapies for advanced gastroenteropancreatic neuroendocrine tumors. (2011) (5)
- Colorectal Cancer Management: Evolving Recommendations (2007) (5)
- Hematologic toxicity of cisplatin and mitoraycin in combination for squamous cell carcinoma of esophagus (1985) (5)
- Evaluation of nilotinib (N) in advanced GIST previously treated with imatinib mesylate (IM) and sunitinib (S). (2010) (5)
- A randomized study of post-operative radiotherapy combined with chemotherapy in rectal carcinoma: An eastern cooperative oncology group study (1981) (5)
- Phase I and pharmacokinetic study of irinotecan in combination with raltitrexed (2002) (5)
- Phase II trial of topotecan in advanced pancreatic cancer (1993) (5)
- Important gaps in patients' knowledge prior to chemotherapy. (1983) (5)
- Impacts of pembrolizumab therapy on immune phenotype in patients with high-grade neuroendocrine neoplasms (2021) (5)
- Specific compliance issues in an antiestrogen trial of women at risk for breast cancer. (1991) (5)
- Neuroendocrine tumors. (2019) (5)
- Feasibility of assessing quality in medical oncology practices. (2001) (5)
- Distinctive chromosomal instability (CIN) patterns and its prognostic value in pancreatic neuroendocrine tumors (pNET). (2016) (4)
- Removing barriers to clinical research in community hospitals—The Fox Chase Cancer Center Partners experience (2007) (4)
- Predictors of future breast cancer risk. (1993) (4)
- Physical activity intervention for patients with advanced pancreatic cancer. (2017) (4)
- Anal canal cancer clinical practice guidelines in oncology. (2005) (4)
- Cancer prevention and control investigators: the need for high quality training programs. (1996) (4)
- Breast self-examination post mastectomy: empirical findings and their implications. (1983) (4)
- Management of esophageal cancer. (1990) (4)
- The experience of cancer warning signs in a general population and its implications for public education. (1988) (4)
- Cancer pain management: a clinical trial of an education program for patients. (1986) (4)
- Cancer patients' preferences for educational methods and media. (1982) (3)
- Postoperative adjuvant chemotherapy (CTX) use in patients (Pts) with stage II/III rectal cancer treated with neoadjuvant therapy: A National Comprehensive Cancer Network (NCCN) analysis. (2011) (3)
- Oncologic medicine : clinical topics and practical management (1976) (3)
- Cancer prevention and control priorities for the year 2000. A commentary (1994) (3)
- Gallbladder adenocarcinoma: Prognostic significance of tumor acid mucopolysaccharide content (1986) (3)
- Ten years of progress in colon cancer therapy. (2012) (3)
- Using custom protein microarrays to identify autoantibody biomarkers for the early detection of breast cancer. (2009) (3)
- Phase II study of methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer. (1976) (3)
- Eastern Cooperative Oncology Group phase II studies in advanced measurable colorectal cancer. I. Razoxane, Yoshi-864, piperazinedione, and lomustine. (1985) (3)
- Profiling of 1,350 neuroendocrine tumors for identification of multiple potential drug targets. (2014) (3)
- Use of multiple data sources in planning a smoking cessation program for a defined population. (1988) (3)
- Process evaluation of a minimal-contact smoking cessation program in an urban nutritional assistance (WIC) program. (1990) (3)
- Minimal brain dysfunction and methylphenidate. (1971) (3)
- Reaching towards 2000: development and evaluation of a community education program on diet and cancer prevention. (1988) (2)
- Phase II trial of PCNU in advanced colorectal carcinoma An Eastern Cooperative Oncology Group pilot study (1984) (2)
- The impact of a single disease site treatment facility on prostate cancer care in a community-hospital based radiation oncology practice (2008) (2)
- Free breast cancer screening utilization and results. (1987) (2)
- Comparison of Internist and Oncologist Evaluations of Cancer Patients' Need for Hospitalization (1984) (2)
- Surreptitious self-administration of heparin. (1970) (2)
- The role of the physician in changing patients' smoking behavior: results of a survey of physicians. (1986) (2)
- A new era for cancer prevention and control research. (1999) (2)
- Assessing the impact of a targeted educational initiative on colorectal cancer lymph node retrieval: A Fox Chase Cancer Center Partners' quality initiative. (2016) (2)
- Oral cancer screening in the dental office. (1982) (2)
- Pala Versus Streptozotocin, Doxorubicin, and Meccnu in the Treatment of Patients With Advanced Pancreatic Carcinoma (1998) (2)
- Physiochemical Composition of Tobacco Smoke (2003) (2)
- Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trials (2020) (2)
- Profiling of a global cohort of 1,250 neuroendocrine tumors to identify multiple potential drug targets. (2014) (2)
- Carcinogenic and Genotoxic Effects of Tobacco Constituents (2003) (2)
- Cancer control objectives for the year 2000. (1986) (1)
- Cancer prevention: From concept to practice (2000) (1)
- Comparative methodologies for the community distribution of a cancer risk assessment form. (1987) (1)
- Phase I/Pharmacokinetic Réévaluation of ThioTEPA1 (1991) (1)
- Personal and ambient factors in cancer causation in an urban population. (1986) (1)
- Phase II study of ICRF-159 in refractory metastatic breast cancer. (1979) (1)
- Cancer control through a network of community hospitals. (1983) (1)
- Approaches for Smoking Cessation (2003) (1)
- Cisplatin, doxorubicin, and 5-FU in combination for advanced gastric cancer. (1984) (1)
- Current and future cancer control activities in cancer programs in the United States. (1987) (1)
- Advances in cancer control. Research and development. Proceedings of the joint meeting sponsored by the Association of American Cancer Institutes and the Association of Community Cancer Centers. Washington, D.C. March 4-7, 1982. (1983) (1)
- Role of education in screening for cancer control: results of follow up in two screening programs. (1982) (1)
- Fox Chase Network: Fox Chase Cancer Center's community hospital affiliation program. (2000) (1)
- Research in cancer patient education and compliance. (1983) (1)
- Development of a nutrition education program for a blue collar community. (1988) (1)
- Cancer and the elderly: a cancer control challenge. (1983) (1)
- Discussing colorectal cancer. (2009) (1)
- Successful Treatment of a Patient with Pancytopenia (1972) (1)
- Lidocaine: an anti-tussive for ophthalmic surgery. (1988) (1)
- Anal Carcinoma , Version 2 . 2018 Clinical Practice Guidelines in Oncology (2018) (0)
- Staging and Prognosis (2003) (0)
- Management (Figure 100-3) (2003) (0)
- Assessing the treatment quality of elderly patients with stage III colon cancer in a large community oncology network: A Fox Chase Cancer Center Partners (FCCCP) quality initiative (2008) (0)
- Reviews and Notes: Oncology: Atlas of Diagnostic Oncology (1996) (0)
- Erratum to “Psychosocial correlates of intention to undergo prophylactic oophorectomy among women with a family history of ovarian cancer” [Prev. Med. 37 (2003) 424–431] (2004) (0)
- Physician burnout. (2013) (0)
- ASSESSING MEDICAL ONCOLOGY OFFICE PRACTICES FOR QUALITY IMPROVEMENT: A FOX CHASE CANCER CENTER PARTNERS INITIATIVE (2011) (0)
- Phase I trial of ICRF-159 in combination with 1.3 bis-(2-chloroethyl)-1-nitrosourea (MeCCNU). (1978) (0)
- Trends in Intensity Modulated Radiation Therapy Use for Locally-Advanced Rectal Cancer at National Comprehensive Cancer Network (NCCN) Centers (2013) (0)
- Overview of the cancer control program at the Fox Chase Cancer Center. (1981) (0)
- Rectal Cancer NCCN Rectal Cancer Panel Members Continue (0)
- Abstract P4-02-05: A blinded multicenter phase II study of a panel of plasma biomarkers for the detection of triple negative breast cancer (2015) (0)
- Innovative approach to alter fatalistic misconceptions in a high cancer mortality community. (1987) (0)
- The role of gender and monitoring on cancer prevention-related beliefs among worksite employees (2003) (0)
- Incidence of minimally invasive colorectal cancer (CRC) surgery in patients treated at NCCN institutions (2016) (0)
- Brief P hysician-Initia ted Q uit-Smoking S trategies f or C linical Oncology S ettings: A T rial C oordinated b y t he E astern Cooperative O ncology G roup (2003) (0)
- RNA profiling of neuroendocrine tumors (NETs) to define new targets and mechanisms of progression. (2017) (0)
- Colorectal cancer screening in a defined population. (1988) (0)
- Preoperative chemoradiotherapy for stage I-III adenocarcinoma of the pancreas: The Fox Chase Cancer Center experience with 63 patients (1994) (0)
- Assessing community hospital compliance with NCCN breast cancer guidelines in diagnosis and treatment of stage IIb and IIIa breast cancer: A Fox Chase Cancer Center Partners (FCCCP) initiative (2007) (0)
- The Use of Infusional 5-Fluorouracil, Mitomycin C, and Radiation as the Primary Management of Esophageal Cancer (1991) (0)
- Methods for collection of stool samples. (1988) (0)
- Cancer control in a defined population: results of the "Beat the Odds" education campaign. (1988) (0)
- 117 Negative post-treatment 18-FDG pet scans may not predict pathologic complete response in patients with rectal cancer undergoing neoadjuvant chemoradiation (2006) (0)
- Ovarian Cancer Prevention Program (1999) (0)
- Effectiveness of Botulinum Toxin Therapy for Essential Blepharospasm (1988) (0)
- Chapter 10 – Prostate Cancer Prevention: Strategies and Realities (2003) (0)
- Commentary (Engstrom/Langer): Management of Cancer in the Elderly (2006) (0)
- Molecular profiling of neuroendocrine tumors (NETs): The Fox Chase Cancer Center (FCCC) experience. (2015) (0)
- AWARD NUMBER: DAMD17-01-1-0006 TITLE: Facilitating Treatment Decision Making, Adjustment, and Coping in Men Newly Diagnosed with Prostate Cancer (2006) (0)
- Book reviews (2005) (0)
- Surveillance for colorectal neoplasia: is patient adherence following treatment a problem? (1993) (0)
- Transcript profiling of neuroendocrine tumors (NETs) to identify new targets and mechanism of progression. (2019) (0)
- DNA Inhibition as an Explanation of Hydroxyurea Induced Megaloblastosis. (1965) (0)
- 2 Chemoprevention of Colorectal Cancer (2006) (0)
- Table 96.3, TNM Staging System in HCC Primary Tumor (T) (2000) (0)
- Construction and Analysis of the NCI-EDRN Breast Cancer Reference Set for Circulating Markers of Disease Running Title : Breast Cancer Reference Set for Circulating Markers (2014) (0)
- P-674 Physician-based smoking cessation treatment for cancer patients: Training, implementation, beliefs, and correlates of adherence (2003) (0)
- Abstract 1318: A protein microarray signature of autoantibody biomarkers for the detection of HER2+ breast cancers (2015) (0)
- Prevention of Tobacco Use (2003) (0)
- Cancer related attitudes and practices in a community experiencing high cancer mortality. (1986) (0)
- Orchiectomy for trophoblastic tumors. (1971) (0)
- Adjuvant Radiotherapy in Merkel Cell Carcinoma: A 20-year Experience at a Single Institution (2011) (0)
- Chemotherapy After Surgery for Stage II Colon Cancer: Clarifying the Controversy (2008) (0)
- A technique for administering a questionnaire to a group with low reading ability. (1982) (0)
- Merkel Cell Carcinoma and Sentinel Lymph Node Evaluation: Outcomes from a Single Institution (2011) (0)
- Advances in cancer control. Screening and prevention research. Proceedings of the Association of Community Cancer Centers, 15th national meeting. Bethesda, Maryland, March 29-April 1, 1989. (1990) (0)
- Neuroendocrine TumorsPractice Guidelines in Oncology (2012) (0)
- Progress in Chemoprevention: AACR Task Force Report (2006) (0)
- Other Primary Hepatic Neoplasms (2003) (0)
- Process and impact evaluation of a cancer screening education program. (1986) (0)
- Rectal Cancer (2018) (0)
- ECOG Phase II Trials of MGBG, Chlorozotocin, COM Multidrug Therapy in Advanced Measurable Colorectal Cancer (1988) (0)
- Abstract A105: Application of national guidelines diminishes racial disparities in end-of-life cancer care (2011) (0)
- NCCN Rectal Cancer , Version 2 . 2018 Clinical Practice Guidelines in Oncology (2018) (0)
- NEUROENDOCRINE TUMORS (2007) (0)
- NCCN Genetic/Familial High-Risk Assessment: Breast Panel Members Genetic/Familial High-Risk Assessment: Breast (2002) (0)
- Genetic Variation in Cancer Susceptibility (2003) (0)
- Dimensions of disease and health promotion implications: comparing images of cancer and heart disease in a blue collar community. (1988) (0)
- Process and impact evaluation of a cancer program for older people. (1987) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Paul F. Engstrom?
Paul F. Engstrom is affiliated with the following schools:
